ArticleHealth science reports2026
Determinants of Poor Glycemic Control in Type 2 Diabetes Patients With Coronary Artery Disease: A Case-Control Study.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Poor glycemic control increases the risk of cardiovascular complications in patients with type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD). The current study identified determinants of poor glycemic control in Iranian T2DM patients with CAD. Methods: This case-control study included T2DM patients with CAD who were admitted to Golestan Hospital in Ahvaz (Iran) during 2 years. Demographic, clinical, and biochemical data were collected. According to their glycemic control status, patients were divided into two groups: uncontrolled glycemia (Group 1, Results: The study assessed 700 T2DM patients with CAD (458 males and 242 females). Their average age was 60.51 ± 9.76 years. Compared to patients with optimal glycemic control, those with uncontrolled glycemia were younger, had higher rates of dyslipidemia, previous myocardial infarction, smoking, chronic kidney disease, hypertension, peripheral artery disease, diabetes for a longer period, higher body mass index (BMI), lower ventricular ejection fraction, greater levels of total cholesterol, HbA1c, fasting blood glucose, triglycerides, triglyceride-glucose (TyG) index, and low-density lipoprotein cholesterol ( Conclusion: This study revealed that CAD patients with good glycemic control had better clinical and cardiovascular status. HbA1c may serve as a valuable parameter for risk stratification in these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.